NCT01050725
Suspended
Not Applicable
Investigating Proteomic Biomarkers of Radiation Therapy Outcome: A Pilot Study
ConditionsCancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Benaroya Research Institute
- Enrollment
- 100
- Locations
- 1
- Status
- Suspended
- Last Updated
- 14 years ago
Overview
Brief Summary
The purpose of this study is to determine whether specific assays of DNA damage repair proteins can be used in patients undergoing radiation therapy. The ultimate goal of this research is to develop clinically useful biomarkers from blood samples that could be used to customize radiation treatment for individuals, leading to reduced side effects and improved outcomes.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients \> 18 years of age with primary lung, esophageal or rectal cancer receiving neo-adjuvant chemoradiotherapy before planned resection
- •patients with clinically localized prostate cancer receiving definitive radiation therapy with external beam treatment. brachytherapy as a boost and/or hormonal therapy are allowed.
- •patients with head and neck, lung, esophageal or cervical cancer who will receive definitive radiotherapy
Exclusion Criteria
- •prior history of chemotherapy given within 6 months before enrollment.
- •prior radiotherapy or radionuclide treatment and/or brachytherapy within 6 months prior to enrollment.
- •unwillingness to comply with tests, protocol, or informed consent.
- •concurrent enrollment on any protocol that would require non-compliance with treatment procedures.
- •chemotherapy required within 2 hours following first dose of XRT.
- •PET scan done within 48 hours of first blood draw.
- •nuclear medicine exposure within 4 days prior to first draw.
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Molecular Biomarkers of Response to Radiation Therapy in Breast CancerBreast CancerRadiotherapy Side EffectNCT06648148Institute of Oncology Ljubljana200
Terminated
Not Applicable
Validation of Radio-induced Damage BiomarkersBone MetastasisMalignant HemopathyNCT02999152Centre Hospitalier Universitaire de Saint Etienne16
Completed
Not Applicable
RNA and Heat Shock Protein Biomarkers in Radiation-induced Fibrosis in Breast CancerBreast CarcinomaFibrosisNCT03000764Institut de Cancérologie de Lorraine20
Active, not recruiting
Not Applicable
Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)Breast CancerNCT03252717Institut du Cancer de Montpellier - Val d'Aurelle500
Active, not recruiting
Not Applicable
Quantification of DNA Repair Products in the Urine After Ultraviolet Radiation of the SkinUltraviolet Rays; InjuryDNA Adduct FormationDNA Damage, Radiation InducedDNA DamageNCT05277961Bispebjerg Hospital80